Pharmacogenomics in gastrointestinal disorders

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

It is anticipated that unraveling the human genome will have a direct impact on the management of specific diseases. Variations or mutations in genes involved in drug metabolism or disease pathophysiology in gastroenterology and hepatology are expected to have effect on response to therapy. The spectrum of diseases is vast. Thus, we focus this review on clinical pharmacogenetics of inflammatory bowel disease, Helicobacter pylori infections, gastroesophageal reflux disease, irritable bowel syndrome, liver transplantation, and colon cancer. Although only a few genotyping tests are used regularly in clinical practice, we anticipate that in the future there will be more routine use of many of the tests described in this review.

Original languageEnglish (US)
Title of host publicationMethods in Molecular Biology
Pages395-412
Number of pages18
Volume448
DOIs
StatePublished - 2008

Publication series

NameMethods in Molecular Biology
Volume448
ISSN (Print)10643745

Fingerprint

Pharmacogenetics
Gastroenterology
Irritable Bowel Syndrome
Helicobacter Infections
Human Genome
Liver Neoplasms
Disease Management
Gastroesophageal Reflux
Inflammatory Bowel Diseases
Helicobacter pylori
Liver Transplantation
Colonic Neoplasms
Mutation
Pharmaceutical Preparations
Genes
Therapeutics

Keywords

  • Colon cancer
  • Functional dyspepsia
  • Functional gastrointestinal disorders
  • Gastroesophageal reflux disease
  • Helicobacter pylori infection
  • Inflammatory bowel disease
  • Irritable bowel syndrome
  • Liver transplantation
  • Pharmacogenetics

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology

Cite this

Camilleri, M., & Saito, Y. A. (2008). Pharmacogenomics in gastrointestinal disorders. In Methods in Molecular Biology (Vol. 448, pp. 395-412). (Methods in Molecular Biology; Vol. 448). https://doi.org/10.1007/978-1-59745-205-2-13

Pharmacogenomics in gastrointestinal disorders. / Camilleri, Michael; Saito, Yuri A.

Methods in Molecular Biology. Vol. 448 2008. p. 395-412 (Methods in Molecular Biology; Vol. 448).

Research output: Chapter in Book/Report/Conference proceedingChapter

Camilleri, M & Saito, YA 2008, Pharmacogenomics in gastrointestinal disorders. in Methods in Molecular Biology. vol. 448, Methods in Molecular Biology, vol. 448, pp. 395-412. https://doi.org/10.1007/978-1-59745-205-2-13
Camilleri M, Saito YA. Pharmacogenomics in gastrointestinal disorders. In Methods in Molecular Biology. Vol. 448. 2008. p. 395-412. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-59745-205-2-13
Camilleri, Michael ; Saito, Yuri A. / Pharmacogenomics in gastrointestinal disorders. Methods in Molecular Biology. Vol. 448 2008. pp. 395-412 (Methods in Molecular Biology).
@inbook{d1e5b2ea2d4544b5a18a70f4af55c55d,
title = "Pharmacogenomics in gastrointestinal disorders",
abstract = "It is anticipated that unraveling the human genome will have a direct impact on the management of specific diseases. Variations or mutations in genes involved in drug metabolism or disease pathophysiology in gastroenterology and hepatology are expected to have effect on response to therapy. The spectrum of diseases is vast. Thus, we focus this review on clinical pharmacogenetics of inflammatory bowel disease, Helicobacter pylori infections, gastroesophageal reflux disease, irritable bowel syndrome, liver transplantation, and colon cancer. Although only a few genotyping tests are used regularly in clinical practice, we anticipate that in the future there will be more routine use of many of the tests described in this review.",
keywords = "Colon cancer, Functional dyspepsia, Functional gastrointestinal disorders, Gastroesophageal reflux disease, Helicobacter pylori infection, Inflammatory bowel disease, Irritable bowel syndrome, Liver transplantation, Pharmacogenetics",
author = "Michael Camilleri and Saito, {Yuri A.}",
year = "2008",
doi = "10.1007/978-1-59745-205-2-13",
language = "English (US)",
isbn = "9781588298874",
volume = "448",
series = "Methods in Molecular Biology",
pages = "395--412",
booktitle = "Methods in Molecular Biology",

}

TY - CHAP

T1 - Pharmacogenomics in gastrointestinal disorders

AU - Camilleri, Michael

AU - Saito, Yuri A.

PY - 2008

Y1 - 2008

N2 - It is anticipated that unraveling the human genome will have a direct impact on the management of specific diseases. Variations or mutations in genes involved in drug metabolism or disease pathophysiology in gastroenterology and hepatology are expected to have effect on response to therapy. The spectrum of diseases is vast. Thus, we focus this review on clinical pharmacogenetics of inflammatory bowel disease, Helicobacter pylori infections, gastroesophageal reflux disease, irritable bowel syndrome, liver transplantation, and colon cancer. Although only a few genotyping tests are used regularly in clinical practice, we anticipate that in the future there will be more routine use of many of the tests described in this review.

AB - It is anticipated that unraveling the human genome will have a direct impact on the management of specific diseases. Variations or mutations in genes involved in drug metabolism or disease pathophysiology in gastroenterology and hepatology are expected to have effect on response to therapy. The spectrum of diseases is vast. Thus, we focus this review on clinical pharmacogenetics of inflammatory bowel disease, Helicobacter pylori infections, gastroesophageal reflux disease, irritable bowel syndrome, liver transplantation, and colon cancer. Although only a few genotyping tests are used regularly in clinical practice, we anticipate that in the future there will be more routine use of many of the tests described in this review.

KW - Colon cancer

KW - Functional dyspepsia

KW - Functional gastrointestinal disorders

KW - Gastroesophageal reflux disease

KW - Helicobacter pylori infection

KW - Inflammatory bowel disease

KW - Irritable bowel syndrome

KW - Liver transplantation

KW - Pharmacogenetics

UR - http://www.scopus.com/inward/record.url?scp=43549091159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43549091159&partnerID=8YFLogxK

U2 - 10.1007/978-1-59745-205-2-13

DO - 10.1007/978-1-59745-205-2-13

M3 - Chapter

C2 - 18370239

SN - 9781588298874

VL - 448

T3 - Methods in Molecular Biology

SP - 395

EP - 412

BT - Methods in Molecular Biology

ER -